Bill Text: NY A01691 | 2011-2012 | General Assembly | Introduced


Bill Title: Provides that health maintenance organizations shall provide market access to diagnostic laboratories.

Spectrum: Partisan Bill (Democrat 2-0)

Status: (Introduced - Dead) 2012-01-04 - referred to health [A01691 Detail]

Download: New_York-2011-A01691-Introduced.html
                           S T A T E   O F   N E W   Y O R K
       ________________________________________________________________________
                                         1691
                              2011-2012 Regular Sessions
                                 I N  A S S E M B L Y
                                   January 11, 2011
                                      ___________
       Introduced by M. of A. ORTIZ -- Multi-Sponsored by -- M. of A. CRESPO --
         read once and referred to the Committee on Health
       AN ACT to amend the public health law and the insurance law, in relation
         to  providing  access to diagnostic laboratories by patients in health
         maintenance organizations
         THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
       BLY, DO ENACT AS FOLLOWS:
    1    Section  1. Section 4406 of the public health law is amended by adding
    2  a new subdivision 6 to read as follows:
    3    6. NOTWITHSTANDING ANY OTHER PROVISION  OF  LAW,  IF  AN  ENROLLEE  IS
    4  REFERRED  BY  AN  IN-PLAN  PROVIDER TO A PROVIDER OF CLINICAL LABORATORY
    5  SERVICES NOT PARTICIPATING IN THE PLAN (A "NON-PARTICIPATING PROVIDER"),
    6  ANY SERVICE PROVIDED BY A NON-PARTICIPATING PROVIDER THAT  WOULD  OTHER-
    7  WISE  BE PAID FOR BY THE PLAN TO OTHER NON-PARTICIPATING PROVIDERS SHALL
    8  BE PAID FOR BY THE PLAN, AND THE PLAN SHALL BE RESPONSIBLE  FOR  PAYMENT
    9  DIRECTLY  TO  THE NON-PARTICIPATING PROVIDER FOR THAT SERVICE IN ACCORD-
   10  ANCE WITH THE TIME FRAME FOR SUCH PAYMENTS SET FORTH  IN  SECTION  THREE
   11  THOUSAND  TWO  HUNDRED  TWENTY-FOUR-A  OF  THE  INSURANCE LAW; PROVIDED,
   12  HOWEVER, THAT THE ENROLLEE  SHALL  BE  RESPONSIBLE  FOR  ANY  APPLICABLE
   13  COPAY,  COINSURANCE  OR DEDUCTIBLE FOR SUCH SERVICES. CLINICAL LABORATO-
   14  RIES  SEEKING  REIMBURSEMENT  PURSUANT  TO  THIS  ARTICLE  FOR  SERVICES
   15  RENDERED  SHALL  DIRECTLY  BILL  THE  PLAN  WHOSE  ENROLLEE RECEIVED THE
   16  SERVICES. ANY PAYMENT MADE BY A PLAN DIRECTLY  TO  THE  ENROLLEE  RATHER
   17  THAN  TO THE CLINICAL LABORATORY SEEKING REIMBURSEMENT SHALL NOT SATISFY
   18  THE PLAN'S PAYMENT OBLIGATION TO THE CLINICAL LABORATORY.
   19    S 2. Section 4406-c of the public health law is amended by adding  two
   20  new subdivisions 4-a and 4-b to read as follows:
   21    4-A.  NO HEALTH CARE PLAN, NOT-FOR-PROFIT OR FOR-PROFIT HEALTH MAINTE-
   22  NANCE ORGANIZATION, PREFERRED PROVIDER ORGANIZATION,  POINT  OF  SERVICE
   23  PLAN,  GOVERNMENT  SUBSIDIZED  HEALTH  CARE  PLAN  OR  SELF INSURED PLAN
   24  (COLLECTIVELY, "PLAN")  SHALL  EXCLUDE  FROM  PARTICIPATING  WITHIN  ITS
        EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                             [ ] is old law to be omitted.
                                                                  LBD03933-01-1
       A. 1691                             2
    1  NETWORK  ANY  PROVIDER  OF  CLINICAL  LABORATORY SERVICES THAT MEETS THE
    2  FOLLOWING REQUIREMENTS: (A) SUCH PROVIDER  IS  LICENSED  AS  A  MEDICARE
    3  PROVIDER  BY  THE UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES;
    4  (B)  SUCH  PROVIDER  IS  EITHER  ACCREDITED  BY  THE COLLEGE OF AMERICAN
    5  PATHOLOGISTS, OR LICENSED BY THE NEW YORK STATE  DEPARTMENT  OF  HEALTH;
    6  AND  (C)  SUCH  PROVIDER  SUBMITS  ELECTRONIC CLAIMS TO THE PLAN FOR THE
    7  PAYMENT OF CLINICAL LABORATORY SERVICES RENDERED TO ENROLLEES. EACH PLAN
    8  SHALL DIRECTLY PAY FOR CLINICAL LABORATORY SERVICES RENDERED  TO  ENROL-
    9  LEES  BY  ANY PROVIDER OF CLINICAL LABORATORY SERVICES PRACTICING WITHIN
   10  ITS NETWORK IN ACCORDANCE WITH THE TIME  FRAME  FOR  SUCH  PAYMENTS  SET
   11  FORTH  IN SECTION THREE THOUSAND TWO HUNDRED TWENTY-FOUR-A OF THE INSUR-
   12  ANCE LAW; PROVIDED, HOWEVER, THAT THE ENROLLEE SHALL BE RESPONSIBLE  FOR
   13  ANY APPLICABLE COPAY, COINSURANCE OR DEDUCTIBLE FOR SUCH SERVICES.
   14    4-B. NOTWITHSTANDING ANY OTHER PROVISION OF LAW, IN NO EVENT SHALL ANY
   15  PLAN: (A) REIMBURSE ANY IN-PLAN PROVIDER OF CLINICAL LABORATORY SERVICES
   16  FOR  A  PARTICULAR  LABORATORY  TEST  BUT  NOT REIMBURSE ANOTHER IN-PLAN
   17  PROVIDER OF CLINICAL LABORATORY SERVICES FOR THAT LABORATORY  TEST;  (B)
   18  ASSIGN  PREFERENTIAL  STATUS  NOR  PROVIDE  PREFERENTIAL  TREATMENT TO A
   19  PROVIDER OF CLINICAL LABORATORY SERVICES PRACTICING WITHIN ITS  NETWORK.
   20  SUCH PROHIBITED PREFERENTIAL TREATMENT SHALL INCLUDE, BUT IS NOT LIMITED
   21  TO,  MAINTAINING  A  SUBSTANTIALLY DIFFERENT RATE OF PAYMENT OR FEES FOR
   22  SIMILAR PRODUCTS AND SERVICES PROVIDED  BY  ONE  IN-PLAN  PROVIDER  OVER
   23  THOSE  OF  OTHER  IN-PLAN PROVIDERS, OR ESTABLISHING A PAYMENT PROCEDURE
   24  WITH ONE IN-PLAN PROVIDER AS OPPOSED TO OTHER IN-PLAN PROVIDERS KNOWN TO
   25  LIKELY RESULT IN THE LOSS OF PAYMENT FOR  SUCH  IN-PLAN  PROVIDERS;  (C)
   26  ESTABLISH DIFFERENT PERFORMANCE MEASURES OR REQUIREMENTS FOR ONE IN-PLAN
   27  PROVIDER  OVER  THOSE  OF OTHER IN-PLAN PROVIDERS OF CLINICAL LABORATORY
   28  SERVICES, INCLUDING BUT NOT LIMITED TO, THE NUMBER  OF  PATIENT  SERVICE
   29  CENTERS REQUIRED TO BE OPERATED IN A COVERED AREA OR FLUCTUATING REPORT-
   30  ING  GUIDELINES  AND REQUIREMENTS; (D) SUBCONTRACT THE MANAGEMENT OF THE
   31  NETWORK TO AN IN-PLAN LABORATORY THAT COLLECTS A MANAGEMENT FEE FOR SUCH
   32  MANAGEMENT SERVICES; OR (E) TREAT ANY ENROLLEE UTILIZING THE SERVICES OF
   33  ANY PROVIDER OF  CLINICAL  LABORATORY  SERVICES  PRACTICING  WITHIN  ITS
   34  NETWORK  IN A MANNER WHICH IS NOT THE SAME AS OR SIMILAR IN ALL MATERIAL
   35  RESPECTS TO THE MANNER  IN  WHICH  ALL  OTHER  ENROLLEES  UTILIZING  THE
   36  SERVICES  OF  ANY  PROVIDER  OF  CLINICAL LABORATORY SERVICES PRACTICING
   37  WITHIN ITS NETWORK ARE TREATED.
   38    S 3. Section 4804 of the insurance law is  amended  by  adding  a  new
   39  subsection (g) to read as follows:
   40    (G)  NOTWITHSTANDING  ANY  OTHER  PROVISION  OF  LAW, IF AN INSURED IS
   41  REFERRED BY AN IN-PLAN PROVIDER TO A  PROVIDER  OF  CLINICAL  LABORATORY
   42  SERVICES NOT PARTICIPATING IN THE PLAN (A "NON-PARTICIPATING PROVIDER"),
   43  ANY  SERVICE THAT WOULD OTHERWISE BE COVERED AS AN IN-PLAN SERVICE UNDER
   44  THE PLAN THAT IS PROVIDED BY THE  NON-PARTICIPATING  PROVIDER  SHALL  BE
   45  COVERED,  AND THE ORGANIZATION SHALL BE RESPONSIBLE FOR PAYMENT DIRECTLY
   46  TO THE NON-PARTICIPATING PROVIDER FOR THOSE SERVICES IN ACCORDANCE  WITH
   47  THE TIME FRAME FOR SUCH PAYMENTS SET FORTH IN SECTION THREE THOUSAND TWO
   48  HUNDRED  TWENTY-FOUR-A  OF  THIS  CHAPTER;  PROVIDED,  HOWEVER, THAT THE
   49  INSURED SHALL BE RESPONSIBLE FOR ANY APPLICABLE  COPAY,  COINSURANCE  OR
   50  DEDUCTIBLE  FOR  SUCH SERVICES. CLINICAL LABORATORIES SEEKING REIMBURSE-
   51  MENT PURSUANT TO THIS ARTICLE FOR SERVICES RENDERED SHALL DIRECTLY  BILL
   52  THE  ORGANIZATION  WHOSE INSURED RECEIVED THE SERVICES. ANY PAYMENT MADE
   53  BY AN ORGANIZATION DIRECTLY TO THE INSURED RATHER THAN TO  THE  CLINICAL
   54  LABORATORY  SEEKING  REIMBURSEMENT  SHALL NOT SATISFY THE ORGANIZATION'S
   55  PAYMENT OBLIGATION TO THE CLINICAL LABORATORY.
   56    S 4. This act shall take effect immediately.
feedback